St. Jude Medical (STJ) Receives FDA Clearance for Epiducer
Tweet
Share
E-mailGet Alerts STJ Hot Sheet
Join SI Premium – FREE
St. Jude Medical (NYSE: STJ) reports FDA clearance for the industry-first neurostimulation lead delivery system, Epiducer.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- FDA clears path for Protagenic's PT00114 anxiety drug IND submission
- FDA grants fast track status to Rein Therapeutics drug for lung fibrosis
Create E-mail Alert Related Categories
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
